25 XP   0   0   10

Guangzhou Improve Med Instrument
Buy, Hold or Sell?

Let's analyse Guangzhou Improve Med Instrument together

PenkeI guess you are interested in Guangzhou Improve Med Instrument. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guangzhou Improve Med Instrument. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guangzhou Improve Med Instrument

I send you an email if I find something interesting about Guangzhou Improve Med Instrument.

Quick analysis of Guangzhou Improve Med Instrument (30 sec.)










What can you expect buying and holding a share of Guangzhou Improve Med Instrument? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
97.5%

What is your share worth?

Current worth
¥2.67
Expected worth in 1 year
¥2.23
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
¥-0.39
Return On Investment
-7.0%

For what price can you sell your share?

Current Price per Share
¥5.52
Expected price per share
¥3.44 - ¥6.11
How sure are you?
50%

1. Valuation of Guangzhou Improve Med Instrument (5 min.)




Live pricePrice per Share (EOD)

¥5.52

Intrinsic Value Per Share

¥9.23 - ¥11.04

Total Value Per Share

¥11.90 - ¥13.71

2. Growth of Guangzhou Improve Med Instrument (5 min.)




Is Guangzhou Improve Med Instrument growing?

Current yearPrevious yearGrowGrow %
How rich?$114.3m$137.3m-$22.7m-19.8%

How much money is Guangzhou Improve Med Instrument making?

Current yearPrevious yearGrowGrow %
Making money-$4.7m-$2.5m-$2.2m-46.6%
Net Profit Margin-18.9%-9.9%--

How much money comes from the company's main activities?

3. Financial Health of Guangzhou Improve Med Instrument (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#98 / 173

Most Revenue
#112 / 173

Most Profit
#142 / 173

Most Efficient
#130 / 173

What can you expect buying and holding a share of Guangzhou Improve Med Instrument? (5 min.)

Welcome investor! Guangzhou Improve Med Instrument's management wants to use your money to grow the business. In return you get a share of Guangzhou Improve Med Instrument.

What can you expect buying and holding a share of Guangzhou Improve Med Instrument?

First you should know what it really means to hold a share of Guangzhou Improve Med Instrument. And how you can make/lose money.

Speculation

The Price per Share of Guangzhou Improve Med Instrument is ¥5.52. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Guangzhou Improve Med Instrument.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Guangzhou Improve Med Instrument, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.67. Based on the TTM, the Book Value Change Per Share is ¥-0.11 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Guangzhou Improve Med Instrument.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.00-0.1%-0.02-0.3%-0.01-0.1%0.00-0.1%0.000.0%
Usd Book Value Change Per Share0.000.0%-0.02-0.3%-0.01-0.2%0.00-0.1%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.1%0.000.1%0.000.1%
Usd Total Gains Per Share0.000.0%-0.01-0.2%-0.01-0.1%0.000.0%0.000.1%
Usd Price Per Share1.06-1.00-1.15-1.18-1.43-
Price to Earnings Ratio-81.23--56.89-57.24-24.47-77.98-
Price-to-Total Gains Ratio-617.34-1.02--57.56-68.24-166.78-
Price to Book Ratio2.86-2.71-2.58-2.83-3.57-
Price-to-Total Gains Ratio-617.34-1.02--57.56-68.24-166.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.763968
Number of shares1308
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (1308 shares)-17.49-0.17
Gains per Year (1308 shares)-69.96-0.68
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
110-80-8016-17-11
221-161-15032-34-12
331-241-22048-50-13
442-321-29064-67-14
552-402-36081-84-15
662-482-43097-101-16
773-562-500113-118-17
883-643-570129-134-18
993-723-640145-151-19
10104-803-710161-168-20

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%4.08.00.033.3%11.09.00.055.0%30.09.01.075.0%47.09.01.082.5%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%10.010.00.050.0%26.014.00.065.0%43.014.00.075.4%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.01.097.5%53.00.04.093.0%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%12.08.00.060.0%30.010.00.075.0%47.010.00.082.5%

Fundamentals of Guangzhou Improve Med Instrument

About Guangzhou Improve Med Instrument

Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising urine, feces, and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company also offers offers specimen processing equipment, including evacuated blood collection systems, evacuated blood collection tubes, multi-sample needles, blood collection sets, tourniquets and disposable tourniquets, urine collection systems, and holders under IMPROVACUTER brand name; and IMPROMINI capillary blood collection systems, IMPROSWAB microbiological transportation systems, IMPRONURSE infusion pumps and syringe pumps, LONGX urine analysis systems, in-vitro diagnostic reagents, IMPROSAFE safety blood collection needles, IMPROSWAB microbiological transport swabs, IMPROVE sharps containers, liquid biopsy pre-analytical systems, etc. In addition, it provides clinical nursing products, including automatic, handheld, pulsewave, and smart wireless blood pressure monitors; and intelligent management solutions, such as blood collection tube preparation systems, friendly graphic user interfaces, intelligent sorters, multi-function blood collection tables, intelligent queue systems, urine collection tube preparation systems, automatic tube packer systems, and consumable labels, as well as CryoMax vials and liquid nitrogen freezing storage boxes. The company was formerly known as Guangzhou Improve Medical Instruments Co., Ltd. Improve Medical Instruments Co., Ltd. was founded in 1996 and is headquartered in Guangzhou, China.

Fundamental data was last updated by Penke on 2024-03-25 21:18:08.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Guangzhou Improve Med Instrument.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Guangzhou Improve Med Instrument earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Guangzhou Improve Med Instrument to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -4.8% means that ¥-0.05 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guangzhou Improve Med Instrument:

  • The MRQ is -4.8%. The company is making a loss. -1
  • The TTM is -18.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-4.8%TTM-18.9%+14.1%
TTM-18.9%YOY-9.9%-9.0%
TTM-18.9%5Y-5.3%-13.7%
5Y-5.3%10Y0.7%-6.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.8%6.2%-11.0%
TTM-18.9%7.4%-26.3%
YOY-9.9%8.0%-17.9%
5Y-5.3%7.1%-12.4%
10Y0.7%7.7%-7.0%
1.1.2. Return on Assets

Shows how efficient Guangzhou Improve Med Instrument is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Guangzhou Improve Med Instrument to the Medical Instruments & Supplies industry mean.
  • -0.5% Return on Assets means that Guangzhou Improve Med Instrument generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guangzhou Improve Med Instrument:

  • The MRQ is -0.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.5%TTM-2.2%+1.7%
TTM-2.2%YOY-1.0%-1.2%
TTM-2.2%5Y-0.5%-1.7%
5Y-0.5%10Y0.1%-0.6%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.5%1.2%-1.7%
TTM-2.2%1.2%-3.4%
YOY-1.0%1.7%-2.7%
5Y-0.5%1.6%-2.1%
10Y0.1%1.6%-1.5%
1.1.3. Return on Equity

Shows how efficient Guangzhou Improve Med Instrument is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Guangzhou Improve Med Instrument to the Medical Instruments & Supplies industry mean.
  • -0.9% Return on Equity means Guangzhou Improve Med Instrument generated ¥-0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guangzhou Improve Med Instrument:

  • The MRQ is -0.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-4.4%+3.5%
TTM-4.4%YOY-1.9%-2.5%
TTM-4.4%5Y-1.1%-3.3%
5Y-1.1%10Y0.0%-1.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.9%2.3%-3.2%
TTM-4.4%2.6%-7.0%
YOY-1.9%3.1%-5.0%
5Y-1.1%3.2%-4.3%
10Y0.0%3.0%-3.0%

1.2. Operating Efficiency of Guangzhou Improve Med Instrument.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Guangzhou Improve Med Instrument is operating .

  • Measures how much profit Guangzhou Improve Med Instrument makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Guangzhou Improve Med Instrument to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guangzhou Improve Med Instrument:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-8.5%+8.5%
TTM-8.5%YOY-2.2%-6.3%
TTM-8.5%5Y3.5%-12.0%
5Y3.5%10Y2.1%+1.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%-7.9%
TTM-8.5%6.4%-14.9%
YOY-2.2%10.7%-12.9%
5Y3.5%10.0%-6.5%
10Y2.1%8.4%-6.3%
1.2.2. Operating Ratio

Measures how efficient Guangzhou Improve Med Instrument is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.58 means that the operating costs are ¥1.58 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guangzhou Improve Med Instrument:

  • The MRQ is 1.581. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.645. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.581TTM1.645-0.064
TTM1.645YOY1.595+0.050
TTM1.6455Y1.540+0.105
5Y1.54010Y1.074+0.466
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5811.099+0.482
TTM1.6451.149+0.496
YOY1.5951.109+0.486
5Y1.5401.101+0.439
10Y1.0741.055+0.019

1.3. Liquidity of Guangzhou Improve Med Instrument.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Guangzhou Improve Med Instrument is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.25 means the company has ¥1.25 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guangzhou Improve Med Instrument:

  • The MRQ is 1.251. The company is just able to pay all its short-term debts.
  • The TTM is 1.189. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.251TTM1.189+0.062
TTM1.189YOY1.231-0.042
TTM1.1895Y1.618-0.429
5Y1.61810Y0.916+0.702
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2512.385-1.134
TTM1.1892.589-1.400
YOY1.2312.582-1.351
5Y1.6182.635-1.017
10Y0.9162.614-1.698
1.3.2. Quick Ratio

Measures if Guangzhou Improve Med Instrument is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Guangzhou Improve Med Instrument to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.33 means the company can pay off ¥0.33 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guangzhou Improve Med Instrument:

  • The MRQ is 0.330. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.434. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.330TTM0.434-0.104
TTM0.434YOY0.522-0.088
TTM0.4345Y0.723-0.289
5Y0.72310Y0.908-0.185
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3301.165-0.835
TTM0.4341.172-0.738
YOY0.5221.283-0.761
5Y0.7231.392-0.669
10Y0.9081.477-0.569

1.4. Solvency of Guangzhou Improve Med Instrument.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Guangzhou Improve Med Instrument assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Guangzhou Improve Med Instrument to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.44 means that Guangzhou Improve Med Instrument assets are financed with 43.9% credit (debt) and the remaining percentage (100% - 43.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guangzhou Improve Med Instrument:

  • The MRQ is 0.439. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.458. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.439TTM0.458-0.019
TTM0.458YOY0.428+0.030
TTM0.4585Y0.434+0.024
5Y0.43410Y0.377+0.057
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4390.353+0.086
TTM0.4580.355+0.103
YOY0.4280.358+0.070
5Y0.4340.362+0.072
10Y0.3770.369+0.008
1.4.2. Debt to Equity Ratio

Measures if Guangzhou Improve Med Instrument is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Guangzhou Improve Med Instrument to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 82.1% means that company has ¥0.82 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guangzhou Improve Med Instrument:

  • The MRQ is 0.821. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.885. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.821TTM0.885-0.064
TTM0.885YOY0.774+0.111
TTM0.8855Y0.786+0.099
5Y0.78610Y0.651+0.134
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8210.541+0.280
TTM0.8850.545+0.340
YOY0.7740.529+0.245
5Y0.7860.640+0.146
10Y0.6510.665-0.014

2. Market Valuation of Guangzhou Improve Med Instrument

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Guangzhou Improve Med Instrument generates.

  • Above 15 is considered overpriced but always compare Guangzhou Improve Med Instrument to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -81.23 means the investor is paying ¥-81.23 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guangzhou Improve Med Instrument:

  • The EOD is -58.614. Based on the earnings, the company is expensive. -2
  • The MRQ is -81.231. Based on the earnings, the company is expensive. -2
  • The TTM is -56.893. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-58.614MRQ-81.231+22.617
MRQ-81.231TTM-56.893-24.339
TTM-56.893YOY57.241-114.134
TTM-56.8935Y24.467-81.360
5Y24.46710Y77.979-53.512
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-58.61417.153-75.767
MRQ-81.23118.041-99.272
TTM-56.89319.435-76.328
YOY57.24120.661+36.580
5Y24.46721.526+2.941
10Y77.97927.509+50.470
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guangzhou Improve Med Instrument:

  • The EOD is 10.311. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 14.290. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -14.955. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD10.311MRQ14.290-3.979
MRQ14.290TTM-14.955+29.245
TTM-14.955YOY-30.714+15.759
TTM-14.9555Y-27.892+12.937
5Y-27.89210Y-20.509-7.383
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD10.31110.417-0.106
MRQ14.29010.581+3.709
TTM-14.9551.298-16.253
YOY-30.7144.650-35.364
5Y-27.8924.114-32.006
10Y-20.5090.108-20.617
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Guangzhou Improve Med Instrument is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 2.86 means the investor is paying ¥2.86 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Guangzhou Improve Med Instrument:

  • The EOD is 2.066. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.863. Based on the equity, the company is underpriced. +1
  • The TTM is 2.706. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.066MRQ2.863-0.797
MRQ2.863TTM2.706+0.157
TTM2.706YOY2.583+0.123
TTM2.7065Y2.827-0.121
5Y2.82710Y3.573-0.746
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD2.0662.531-0.465
MRQ2.8632.733+0.130
TTM2.7062.7060.000
YOY2.5833.244-0.661
5Y2.8273.824-0.997
10Y3.5734.219-0.646
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guangzhou Improve Med Instrument compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.019-0.111+471%-0.078+301%-0.023+19%0.006-418%
Book Value Per Share--2.6722.6790%3.210-17%2.991-11%2.942-9%
Current Ratio--1.2511.189+5%1.231+2%1.618-23%0.916+37%
Debt To Asset Ratio--0.4390.458-4%0.428+3%0.434+1%0.377+17%
Debt To Equity Ratio--0.8210.885-7%0.774+6%0.786+5%0.651+26%
Dividend Per Share--0.0070.014-51%0.029-76%0.022-68%0.028-75%
Eps---0.024-0.111+372%-0.059+152%-0.023-4%0.002-1046%
Free Cash Flow Per Share--0.1340.022+517%-0.016+112%0.030+347%0.022+512%
Free Cash Flow To Equity Per Share--0.134-0.012+109%-0.059+144%-0.001+101%0.048+180%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max--11.037--------
Intrinsic Value_10Y_min--9.226--------
Intrinsic Value_1Y_max--0.314--------
Intrinsic Value_1Y_min--0.308--------
Intrinsic Value_3Y_max--1.546--------
Intrinsic Value_3Y_min--1.464--------
Intrinsic Value_5Y_max--3.507--------
Intrinsic Value_5Y_min--3.203--------
Market Cap1706712284.160-39%2365282959.7502241608033.750+6%2573984397.375-8%2643086094.193-11%3191351477.977-26%
Net Profit Margin---0.048-0.189+297%-0.099+108%-0.053+10%0.007-743%
Operating Margin----0.0850%-0.0220%0.035-100%0.021-100%
Operating Ratio--1.5811.645-4%1.595-1%1.540+3%1.074+47%
Pb Ratio2.066-39%2.8632.706+6%2.583+11%2.827+1%3.573-20%
Pe Ratio-58.614+28%-81.231-56.893-30%57.241-242%24.467-432%77.979-204%
Price Per Share5.520-39%7.6507.250+6%8.325-8%8.549-11%10.322-26%
Price To Free Cash Flow Ratio10.311-39%14.290-14.955+205%-30.714+315%-27.892+295%-20.509+244%
Price To Total Gains Ratio-445.451+28%-617.3371.023-60463%-57.562-91%68.243-1005%166.781-470%
Quick Ratio--0.3300.434-24%0.522-37%0.723-54%0.908-64%
Return On Assets---0.005-0.022+348%-0.010+111%-0.005-2%0.001-496%
Return On Equity---0.009-0.044+374%-0.019+106%-0.011+15%0.000-333981%
Total Gains Per Share---0.012-0.097+680%-0.049+291%-0.001-92%0.034-136%
Usd Book Value--114340654.284114654936.0730%137362625.231-17%127970110.506-11%125899064.238-9%
Usd Book Value Change Per Share---0.003-0.015+471%-0.011+301%-0.003+19%0.001-418%
Usd Book Value Per Share--0.3700.3710%0.444-17%0.414-11%0.407-9%
Usd Dividend Per Share--0.0010.002-51%0.004-76%0.003-68%0.004-75%
Usd Eps---0.003-0.015+372%-0.008+152%-0.003-4%0.000-1046%
Usd Free Cash Flow--5727105.422928532.489+517%-670668.501+112%1281239.472+347%608566.123+841%
Usd Free Cash Flow Per Share--0.0190.003+517%-0.002+112%0.004+347%0.003+512%
Usd Free Cash Flow To Equity Per Share--0.019-0.002+109%-0.008+144%0.000+101%0.007+180%
Usd Market Cap236208980.128-39%327355161.629310238551.871+6%356239440.597-8%365803115.436-11%441683044.552-26%
Usd Price Per Share0.764-39%1.0591.003+6%1.152-8%1.183-11%1.429-26%
Usd Profit---1007476.171-4751040.766+372%-2536789.656+152%-968597.422-4%106545.611-1046%
Usd Revenue--21124814.32222615029.324-7%25594466.838-17%25151169.362-16%21609538.871-2%
Usd Total Gains Per Share---0.002-0.013+680%-0.007+291%0.000-92%0.005-136%
 EOD+4 -4MRQTTM+23 -11YOY+19 -155Y+11 -2410Y+10 -26

3.2. Fundamental Score

Let's check the fundamental score of Guangzhou Improve Med Instrument based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-58.614
Price to Book Ratio (EOD)Between0-12.066
Net Profit Margin (MRQ)Greater than0-0.048
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.330
Current Ratio (MRQ)Greater than11.251
Debt to Asset Ratio (MRQ)Less than10.439
Debt to Equity Ratio (MRQ)Less than10.821
Return on Equity (MRQ)Greater than0.15-0.009
Return on Assets (MRQ)Greater than0.05-0.005
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Guangzhou Improve Med Instrument based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.783
Ma 20Greater thanMa 505.363
Ma 50Greater thanMa 1005.667
Ma 100Greater thanMa 2006.899
OpenGreater thanClose5.350
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,472,789
Total Liabilities646,629
Total Stockholder Equity787,533
 As reported
Total Liabilities 646,629
Total Stockholder Equity+ 787,533
Total Assets = 1,472,789

Assets

Total Assets1,472,789
Total Current Assets716,469
Long-term Assets756,321
Total Current Assets
Cash And Cash Equivalents 233,855
Short-term Investments 3,000
Net Receivables 185,857
Inventory 131,676
Other Current Assets 75,458
Total Current Assets  (as reported)716,469
Total Current Assets  (calculated)629,845
+/- 86,623
Long-term Assets
Property Plant Equipment 370,117
Goodwill 22,605
Intangible Assets 46,466
Long-term Assets Other 6,064
Long-term Assets  (as reported)756,321
Long-term Assets  (calculated)445,252
+/- 311,068

Liabilities & Shareholders' Equity

Total Current Liabilities572,768
Long-term Liabilities73,861
Total Stockholder Equity787,533
Total Current Liabilities
Short Long Term Debt 375,946
Accounts payable 80,457
Other Current Liabilities 3,543
Total Current Liabilities  (as reported)572,768
Total Current Liabilities  (calculated)459,946
+/- 112,823
Long-term Liabilities
Long term Debt 22,000
Capital Lease Obligations Min Short Term Debt6,279
Long-term Liabilities Other 3,727
Long-term Liabilities  (as reported)73,861
Long-term Liabilities  (calculated)32,006
+/- 41,854
Total Stockholder Equity
Retained Earnings 33,497
Total Stockholder Equity (as reported)787,533
Total Stockholder Equity (calculated)33,497
+/- 754,035
Other
Capital Stock309,187
Common Stock Shares Outstanding 309,187
Net Debt 164,091
Net Invested Capital 1,185,479
Net Working Capital 143,701
Property Plant and Equipment Gross 370,117



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302008-12-312007-12-312006-12-31
> Total Assets 
39,950
73,881
141,687
189,298
201,432
657,842
621,053
627,126
650,130
651,244
672,288
684,935
697,862
716,724
715,025
722,504
752,077
766,532
802,020
809,382
854,713
883,080
874,582
932,030
964,771
1,019,334
1,080,763
1,120,473
1,330,538
1,439,341
1,360,872
1,411,037
1,445,386
1,469,878
1,575,388
1,781,318
1,760,702
1,745,872
1,677,591
1,685,964
1,687,466
1,511,142
1,463,705
1,518,622
1,530,321
1,506,797
1,526,192
1,601,483
1,720,810
1,744,756
1,854,964
1,809,174
1,753,695
1,825,050
1,788,675
1,669,396
1,663,439
1,558,180
1,575,685
1,508,105
1,472,789
1,472,7891,508,1051,575,6851,558,1801,663,4391,669,3961,788,6751,825,0501,753,6951,809,1741,854,9641,744,7561,720,8101,601,4831,526,1921,506,7971,530,3211,518,6221,463,7051,511,1421,687,4661,685,9641,677,5911,745,8721,760,7021,781,3181,575,3881,469,8781,445,3861,411,0371,360,8721,439,3411,330,5381,120,4731,080,7631,019,334964,771932,030874,582883,080854,713809,382802,020766,532752,077722,504715,025716,724697,862684,935672,288651,244650,130627,126621,053657,842201,432189,298141,68773,88139,950
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
704,062
768,785
715,879
678,716
715,854
718,837
702,186
718,344
773,369
814,045
860,047
903,905
773,009
778,140
843,942
832,424
718,793
725,944
718,242
757,846
701,059
716,469
716,469701,059757,846718,242725,944718,793832,424843,942778,140773,009903,905860,047814,045773,369718,344702,186718,837715,854678,716715,879768,785704,062000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
176,366
189,619
234,086
237,641
207,500
134,128
197,142
237,095
152,836
145,913
217,555
246,362
205,449
259,403
345,741
297,924
192,592
199,488
221,046
247,641
215,439
233,855
233,855215,439247,641221,046199,488192,592297,924345,741259,403205,449246,362217,555145,913152,836237,095197,142134,128207,500237,641234,086189,619176,366000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,534
0
6,863
0
59,875
0
53,000
0
70,500
60,000
54,067
59,384
64,000
9,000
0
4,000
2,500
10,500
3,000
3,000
3,000
3,000
3,0003,0003,0003,00010,5002,5004,00009,00064,00059,38454,06760,00070,500053,000059,87506,86306,534000000000000000000000000000000000000000
       Net Receivables 
14,207
24,471
28,404
39,130
43,328
45,279
48,299
62,622
66,606
56,680
68,745
81,785
98,340
81,510
106,135
118,470
132,878
105,661
135,608
156,677
160,410
142,679
154,293
176,555
205,336
167,265
176,382
180,493
219,449
287,978
214,965
318,326
325,855
343,873
296,776
267,678
267,191
365,920
375,452
395,047
439,233
382,747
203,380
217,864
227,431
357,281
352,666
366,338
429,574
417,207
396,686
314,381
312,235
316,883
328,502
335,871
316,541
312,062
252,741
297,406
185,857
185,857297,406252,741312,062316,541335,871328,502316,883312,235314,381396,686417,207429,574366,338352,666357,281227,431217,864203,380382,747439,233395,047375,452365,920267,191267,678296,776343,873325,855318,326214,965287,978219,449180,493176,382167,265205,336176,555154,293142,679160,410156,677135,608105,661132,878118,470106,13581,51098,34081,78568,74556,68066,60662,62248,29945,27943,32839,13028,40424,47114,207
       Other Current Assets 
4,721
3,545
4,162
13,983
23,417
15,853
27,522
25,482
45,343
26,225
37,195
45,359
40,626
28,099
37,361
29,452
45,062
31,274
41,291
49,016
43,230
28,180
46,272
46,521
57,288
31,160
72,482
79,903
71,973
19,313
35,377
25,082
26,145
17,396
24,834
21,798
22,672
20,233
36,579
33,160
37,462
12,966
116,221
166,168
221,976
13,178
28,000
30,684
29,273
20,035
32,775
29,740
35,507
25,037
54,840
31,978
45,023
41,998
120,612
50,202
75,458
75,45850,202120,61241,99845,02331,97854,84025,03735,50729,74032,77520,03529,27330,68428,00013,178221,976166,168116,22112,96637,46233,16036,57920,23322,67221,79824,83417,39626,14525,08235,37719,31371,97379,90372,48231,16057,28846,52146,27228,18043,23049,01641,29131,27445,06229,45237,36128,09940,62645,35937,19526,22545,34325,48227,52215,85323,41713,9834,1623,5454,721
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
784,990
802,768
811,484
804,611
807,848
828,114
906,764
884,710
951,059
1,036,165
975,555
981,108
956,251
950,603
937,495
839,938
817,840
807,045
756,321
756,321807,045817,840839,938937,495950,603956,251981,108975,5551,036,165951,059884,710906,764828,114807,848804,611811,484802,768784,990000000000000000000000000000000000000000000
       Property Plant Equipment 
5,618
8,827
48,490
67,991
76,786
97,003
114,465
115,745
119,045
148,614
145,475
154,690
169,895
203,841
204,595
216,493
219,349
219,677
222,476
244,745
226,753
230,374
228,811
235,361
247,141
281,317
283,057
292,261
296,287
316,121
310,260
308,767
304,346
312,974
306,506
303,041
307,514
321,508
317,042
311,349
308,427
308,897
302,863
300,279
299,216
305,290
304,355
309,859
314,199
347,455
370,252
378,560
378,262
408,544
402,790
408,593
419,289
407,115
395,983
391,140
370,117
370,117391,140395,983407,115419,289408,593402,790408,544378,262378,560370,252347,455314,199309,859304,355305,290299,216300,279302,863308,897308,427311,349317,042321,508307,514303,041306,506312,974304,346308,767310,260316,121296,287292,261283,057281,317247,141235,361228,811230,374226,753244,745222,476219,677219,349216,493204,595203,841169,895154,690145,475148,614119,045115,745114,46597,00376,78667,99148,4908,8275,618
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,254
38,254
38,254
38,254
38,254
38,254
175,503
156,185
156,185
156,185
156,185
156,185
156,185
156,185
156,185
147,157
147,157
147,157
147,157
54,249
53,624
53,624
53,624
53,624
53,624
53,624
53,624
53,624
53,624
74,820
74,820
76,229
76,229
76,229
76,229
22,605
22,605
22,605
22,605
22,60522,60522,60522,60576,22976,22976,22976,22974,82074,82053,62453,62453,62453,62453,62453,62453,62453,62453,62454,249147,157147,157147,157147,157156,185156,185156,185156,185156,185156,185156,185156,185175,50338,25438,25438,25438,25438,25438,2540000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
178,711
178,170
176,798
169,145
168,231
178,793
196,643
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000196,643178,793168,231169,145176,798178,170178,711000000000000000000000000000000000000000
       Intangible Assets 
1,399
6,331
9,116
9,083
9,395
9,173
9,180
8,857
9,209
3,522
33,386
4,611
39,283
9,764
42,944
13,411
62,136
26,975
75,617
8,245
96,970
52,547
90,111
89,499
88,807
100,381
99,386
98,613
258,440
239,394
237,541
236,652
234,871
240,530
241,797
241,889
242,800
279,479
277,178
131,134
135,412
133,013
149,070
95,821
154,668
151,584
150,085
143,570
136,804
135,048
133,013
130,099
128,419
121,506
118,267
115,891
116,020
76,219
74,594
72,937
46,466
46,46672,93774,59476,219116,020115,891118,267121,506128,419130,099133,013135,048136,804143,570150,085151,584154,66895,821149,070133,013135,412131,134277,178279,479242,800241,889241,797240,530234,871236,652237,541239,394258,44098,61399,386100,38188,80789,49990,11152,54796,9708,24575,61726,97562,13613,41142,9449,76439,2834,61133,3863,5229,2098,8579,1809,1739,3959,0839,1166,3311,399
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,026
21,754
24,428
20,251
24,165
19,143
333,134
4,608
11,551
13,987
16,067
17,152
35,004
28,345
14,932
3,636
5,741
4,462
6,064
6,0644,4625,7413,63614,93228,34535,00417,15216,06713,98711,5514,608333,13419,14324,16520,25124,42821,75411,026000000000000000000000000000000000000000000
> Total Liabilities 
20,618
15,615
62,959
81,061
85,893
94,309
55,162
55,274
68,927
58,690
49,528
60,381
62,387
68,470
58,874
62,696
72,657
78,603
68,094
75,168
104,192
110,375
96,137
147,647
196,304
237,330
290,682
328,196
369,479
508,876
423,361
473,960
501,667
515,700
615,439
814,673
792,444
782,153
711,262
718,669
717,809
695,668
646,339
689,128
694,174
668,538
676,738
657,614
674,343
741,943
806,482
687,808
693,841
794,625
795,604
686,259
700,055
737,569
740,903
675,933
646,629
646,629675,933740,903737,569700,055686,259795,604794,625693,841687,808806,482741,943674,343657,614676,738668,538694,174689,128646,339695,668717,809718,669711,262782,153792,444814,673615,439515,700501,667473,960423,361508,876369,479328,196290,682237,330196,304147,64796,137110,375104,19275,16868,09478,60372,65762,69658,87468,47062,38760,38149,52858,69068,92755,27455,16294,30985,89381,06162,95915,61520,618
   > Total Current Liabilities 
19,224
14,565
43,919
56,641
55,223
72,451
49,321
48,678
59,362
52,913
43,082
51,866
53,403
60,017
49,734
53,769
63,942
66,349
56,278
63,623
78,504
82,065
67,746
105,900
137,687
190,942
245,746
283,833
294,082
373,120
288,049
352,252
386,091
412,728
419,540
337,818
321,255
292,831
237,886
341,869
345,838
312,225
259,575
293,828
300,865
573,975
583,077
360,234
375,596
464,632
503,323
607,358
616,483
677,643
682,765
579,034
595,137
638,465
641,731
583,917
572,768
572,768583,917641,731638,465595,137579,034682,765677,643616,483607,358503,323464,632375,596360,234583,077573,975300,865293,828259,575312,225345,838341,869237,886292,831321,255337,818419,540412,728386,091352,252288,049373,120294,082283,833245,746190,942137,687105,90067,74682,06578,50463,62356,27866,34963,94253,76949,73460,01753,40351,86643,08252,91359,36248,67849,32172,45155,22356,64143,91914,56519,224
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124,847
128,962
75,866
100,709
164,894
148,189
135,983
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000135,983148,189164,894100,70975,866128,962124,847000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124,847
128,962
75,866
100,709
164,894
148,189
135,983
132,615
202,621
206,977
207,875
259,885
182,124
196,130
247,300
260,712
363,850
397,346
382,303
416,195
377,451
375,946
375,946377,451416,195382,303397,346363,850260,712247,300196,130182,124259,885207,875206,977202,621132,615135,983148,189164,894100,70975,866128,962124,847000000000000000000000000000000000000000
       Accounts payable 
6,752
10,344
27,988
32,021
38,459
43,423
43,980
44,492
53,912
47,661
36,230
39,746
40,614
47,789
38,966
43,948
51,019
54,465
42,170
38,267
51,079
54,570
44,210
50,190
53,878
60,581
37,921
51,611
59,227
70,903
60,399
59,981
62,280
79,578
64,745
64,602
75,154
70,469
74,035
71,581
71,640
76,089
73,903
62,217
81,767
69,690
68,381
83,373
94,643
103,070
86,867
80,142
80,179
82,468
65,287
77,335
80,799
118,646
97,217
91,050
80,457
80,45791,05097,217118,64680,79977,33565,28782,46880,17980,14286,867103,07094,64383,37368,38169,69081,76762,21773,90376,08971,64071,58174,03570,46975,15464,60264,74579,57862,28059,98160,39970,90359,22751,61137,92160,58153,87850,19044,21054,57051,07938,26742,17054,46551,01943,94838,96647,78940,61439,74636,23047,66153,91244,49243,98043,42338,45932,02127,98810,3446,752
       Other Current Liabilities 
12,472
4,221
3,431
5,120
4,764
5,528
5,341
4,186
5,450
5,252
6,852
12,120
12,789
12,228
10,768
9,821
12,923
11,884
14,108
25,356
27,425
27,495
23,536
45,710
31,793
20,195
30,107
28,721
33,948
65,581
36,351
47,315
42,970
45,367
34,045
54,383
44,535
60,767
56,193
32,367
41,575
28,048
23,940
19,193
385
26,757
48,139
39,646
49,108
71,407
85,677
69,560
73,325
76,825
101,548
96,711
86,159
86,814
94,622
75,114
3,543
3,54375,11494,62286,81486,15996,711101,54876,82573,32569,56085,67771,40749,10839,64648,13926,75738519,19323,94028,04841,57532,36756,19360,76744,53554,38334,04545,36742,97047,31536,35165,58133,94828,72130,10720,19531,79345,71023,53627,49527,42525,35614,10811,88412,9239,82110,76812,22812,78912,1206,8525,2525,4504,1865,3415,5284,7645,1203,4314,22112,472
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
386,764
395,299
393,308
94,563
93,662
297,381
298,747
277,311
303,159
80,450
77,358
116,982
112,838
107,225
104,919
99,104
99,172
92,016
73,861
73,86192,01699,17299,104104,919107,225112,838116,98277,35880,450303,159277,311298,747297,38193,66294,563393,308395,299386,764000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-124,847
-128,962
-75,866
-100,709
-164,894
-148,189
-135,983
0
0
0
0
25,669
13,865
11,978
17,702
14,706
11,235
10,082
6,559
6,448
5,244
6,279
6,2795,2446,4486,55910,08211,23514,70617,70211,97813,86525,6690000-135,983-148,189-164,894-100,709-75,866-128,962-124,847000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
322,050
326,183
324,732
25,500
25,500
229,963
0
0
0
0
0
1,300
1,300
1,300
1,300
4,001
5,294
3,990
3,727
3,7273,9905,2944,0011,3001,3001,3001,30000000229,96325,50025,500324,732326,183322,050000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,322
17,675
29,474
34,084
39,317
37,916
20,754
22,320
23,762
23,650
9,069
10,075
10,718
15,174
8,947
8,191
8,632
5,404
4,815
4,992
4,723
0
04,7234,9924,8155,4048,6328,1918,94715,17410,71810,0759,06923,65023,76222,32020,75437,91639,31734,08429,47417,67522,322000000000000000000000000000000000000000
> Total Stockholder Equity
19,332
58,266
78,728
108,238
115,539
563,533
565,891
571,852
581,203
592,554
599,932
601,354
610,177
620,829
628,507
629,953
639,732
646,031
650,136
650,774
667,158
684,345
690,894
695,956
718,958
729,972
737,934
738,810
907,655
920,683
927,848
927,793
934,814
944,379
950,261
957,390
959,016
954,890
957,848
959,942
962,637
810,836
815,201
827,263
834,063
835,978
847,091
941,377
1,043,379
999,727
1,040,129
1,093,452
1,030,960
1,000,189
962,444
951,843
929,850
784,349
797,984
794,816
787,533
787,533794,816797,984784,349929,850951,843962,4441,000,1891,030,9601,093,4521,040,129999,7271,043,379941,377847,091835,978834,063827,263815,201810,836962,637959,942957,848954,890959,016957,390950,261944,379934,814927,793927,848920,683907,655738,810737,934729,972718,958695,956690,894684,345667,158650,774650,136646,031639,732629,953628,507620,829610,177601,354599,932592,554581,203571,852565,891563,533115,539108,23878,72858,26619,332
   Common Stock
10,000
48,800
48,800
55,400
55,400
74,000
74,000
74,000
74,000
74,000
74,000
148,000
148,000
148,000
148,000
148,000
148,000
148,000
148,000
148,000
148,000
148,000
148,000
296,000
296,000
296,000
296,000
296,000
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
308,796
309,187
309,187
309,187
309,187
309,187
309,187
309,187
0
0309,187309,187309,187309,187309,187309,187309,187308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796308,796296,000296,000296,000296,000296,000148,000148,000148,000148,000148,000148,000148,000148,000148,000148,000148,000148,00074,00074,00074,00074,00074,00074,00055,40055,40048,80048,80010,000
   Retained Earnings 
8,344
7,311
25,726
36,756
44,058
49,941
52,299
58,260
67,611
76,024
83,402
47,824
56,648
64,149
71,607
73,053
82,832
86,494
89,525
90,162
106,547
119,868
145,062
150,121
171,836
184,171
192,118
193,025
204,237
215,127
222,337
221,994
228,922
237,884
243,827
251,113
252,929
249,043
252,533
254,115
256,485
104,521
77,937
89,838
96,352
129,403
140,382
234,730
337,058
285,593
318,698
365,515
309,796
294,280
256,573
245,947
224,001
83,466
97,099
93,930
33,497
33,49793,93097,09983,466224,001245,947256,573294,280309,796365,515318,698285,593337,058234,730140,382129,40396,35289,83877,937104,521256,485254,115252,533249,043252,929251,113243,827237,884228,922221,994222,337215,127204,237193,025192,118184,171171,836150,121145,062119,868106,54790,16289,52586,49482,83273,05371,60764,14956,64847,82483,40276,02467,61158,26052,29949,94144,05836,75625,7267,3118,344
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,522
2,847
3,010
2,863
3,024
3,310
3,269
3,404
3,342
3,016
3,646
3,761
3,579
3,618
-2,332
-2,371
-2,346
-2,393
-7,358
-7,357
-7,355
0
0-7,355-7,357-7,358-2,393-2,346-2,371-2,3323,6183,5793,7613,6463,0163,3423,4043,2693,3103,0242,8633,0102,8472,522000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue653,614
Cost of Revenue-406,873
Gross Profit246,740246,740
 
Operating Income (+$)
Gross Profit246,740
Operating Expense-673,340
Operating Income-19,726-426,599
 
Operating Expense (+$)
Research Development39,660
Selling General Administrative152,141
Selling And Marketing Expenses-
Operating Expense673,340191,800
 
Net Interest Income (+$)
Interest Income2,616
Interest Expense-15,912
Other Finance Cost-5,421
Net Interest Income-18,718
 
Pretax Income (+$)
Operating Income-19,726
Net Interest Income-18,718
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-153,827-19,726
EBIT - interestExpense = -15,912
-137,313
-121,401
Interest Expense15,912
Earnings Before Interest and Taxes (EBIT)--137,915
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-153,827
Tax Provision--21,641
Net Income From Continuing Ops-132,186-132,186
Net Income-137,313
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-18,718
 

Technical Analysis of Guangzhou Improve Med Instrument
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Guangzhou Improve Med Instrument. The general trend of Guangzhou Improve Med Instrument is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Guangzhou Improve Med Instrument's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guangzhou Improve Med Instrument.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.03 < 6.03 < 6.11.

The bearish price targets are: 4.82 > 3.44.

Tweet this
Guangzhou Improve Med Instrument Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guangzhou Improve Med Instrument. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guangzhou Improve Med Instrument Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guangzhou Improve Med Instrument. The current macd is 0.0164784.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Guangzhou Improve Med Instrument price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Guangzhou Improve Med Instrument. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Guangzhou Improve Med Instrument price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Guangzhou Improve Med Instrument Daily Moving Average Convergence/Divergence (MACD) ChartGuangzhou Improve Med Instrument Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guangzhou Improve Med Instrument. The current adx is 25.05.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Guangzhou Improve Med Instrument shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Guangzhou Improve Med Instrument Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guangzhou Improve Med Instrument. The current sar is 6.03649856.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Guangzhou Improve Med Instrument Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guangzhou Improve Med Instrument. The current rsi is 50.78. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Guangzhou Improve Med Instrument Daily Relative Strength Index (RSI) ChartGuangzhou Improve Med Instrument Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guangzhou Improve Med Instrument. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Guangzhou Improve Med Instrument price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Guangzhou Improve Med Instrument Daily Stochastic Oscillator ChartGuangzhou Improve Med Instrument Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guangzhou Improve Med Instrument. The current cci is 27.63.

Guangzhou Improve Med Instrument Daily Commodity Channel Index (CCI) ChartGuangzhou Improve Med Instrument Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guangzhou Improve Med Instrument. The current cmo is 4.92345366.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Guangzhou Improve Med Instrument Daily Chande Momentum Oscillator (CMO) ChartGuangzhou Improve Med Instrument Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guangzhou Improve Med Instrument. The current willr is -51.75438596.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Guangzhou Improve Med Instrument is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Guangzhou Improve Med Instrument Daily Williams %R ChartGuangzhou Improve Med Instrument Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guangzhou Improve Med Instrument.

Guangzhou Improve Med Instrument Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guangzhou Improve Med Instrument. The current atr is 0.32127375.

Guangzhou Improve Med Instrument Daily Average True Range (ATR) ChartGuangzhou Improve Med Instrument Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guangzhou Improve Med Instrument. The current obv is -19,723,382.

Guangzhou Improve Med Instrument Daily On-Balance Volume (OBV) ChartGuangzhou Improve Med Instrument Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guangzhou Improve Med Instrument. The current mfi is 62.97.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Guangzhou Improve Med Instrument Daily Money Flow Index (MFI) ChartGuangzhou Improve Med Instrument Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guangzhou Improve Med Instrument.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Guangzhou Improve Med Instrument Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guangzhou Improve Med Instrument based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.783
Ma 20Greater thanMa 505.363
Ma 50Greater thanMa 1005.667
Ma 100Greater thanMa 2006.899
OpenGreater thanClose5.350
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Guangzhou Improve Med Instrument with someone you think should read this too:
  • Are you bullish or bearish on Guangzhou Improve Med Instrument? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Guangzhou Improve Med Instrument? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guangzhou Improve Med Instrument

I send you an email if I find something interesting about Guangzhou Improve Med Instrument.


Comments

How you think about this?

Leave a comment

Stay informed about Guangzhou Improve Med Instrument.

Receive notifications about Guangzhou Improve Med Instrument in your mailbox!